Open AccessN‐terminal Prohormone Brain Natriuretic Peptide‐proBNP Levels in Ventricular Arrhythmias in Children
Author(s) -
Mazurek Bogusław,
Szydłowski Lesław,
GiecFuglewicz Grażyna,
MarkiewiczŁoskot Grażyna
Publication year - 2009
Publication title -
clinical cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.263
H-Index - 72
eISSN - 1932-8737
pISSN - 0160-9289
DOI - 10.1002/clc.20611
Subject(s) - medicine , asymptomatic , prohormone , natriuretic peptide , cardiology , brain natriuretic peptide , heart failure , population , environmental health , hormone
Background Ventricular arrhythmias are the most common consequences of structural and functional heart diseases, but cases with no evident pathology are also observed. A parameter indicating asymptomatic circulatory failure could support decisions related to possible treatment of ventricular arrhythmias. Hypothesis The study objective was the evaluation of N‐terminal prohormone brain natriuretic peptide (NT‐proBNP) levels in children with ventricular arrhythmias and an attempt to determine if this parameter may be used for diagnosis and prognosis of ventricular arrhythmias. Material and methods The study population was comprised of 36 children age 5 to 17.5 years old with idiopathic ventricular arrhythmias (Group B) graded mild or potentially malignant; 29 patients with mild ventricular arrhythmias were included into Group B1; and 7 patients with potentially malignant cases into Group B2. In all the patients, NT‐proBNP assays were performed. Results The NT‐proBNP levels in Groups B, B1, B2 and the control group (Group K) were as follows: 41.5 ± 15.1 pg/mL, 35.5 ± 18.5 pg/mL, 66.3 ± 24.9 pg/mL and 31.5 ± 15.1 pg/mL, respectively. Between the groups with and without arrhythmias (Group B vs Group K), no statistically significant differences in NT‐proBNP levels were found. However, markedly higher NT‐proBNP levels were shown in the children with potentially malignant arrhythmias (Group B2) compared to the patients with mild arrhythmias (B1) and the control group (Group K). Conclusions The level of NT‐proBNP increases with the severity of ventricular arrhythmia. NT‐proBNP assays can be helpful for diagnosing and grading the severity of ventricular arrhythmias. Copyright © 2009 Wiley Periodicals, Inc.